[1]
|
Fuschillo, S., Martucci, M., Donner, C.F. and Balzano, G. (2012) Airway Bacterial Colonization: The Missing Link between COPD and Cardiovascular Events. Respiratory Medicine, 106, 915-923.
https://doi.org/10.1016/j.rmed.2012.03.023
|
[2]
|
Ghoorah, K., De Soyza, A. and Kunadian, V. (2013) Increased Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease and the Potential Mechanisms Linking the Two Conditions: A Review. Cardiology in Review, 21, 196-202. https://doi.org/10.1097/CRD.0b013e318279e907
|
[3]
|
Hurtado-Nedelec, M., Makni-Maalej, K., Gougerot-Pocidalo, M.A., Dang, P.MC. and El-Benna, J. (2014) Assessment of Priming of the Human Neutrophil Respiratory Burst. In: Quinn, M. and DeLeo, F., Eds., Neutrophil Methods and Protocols, Humana Press, Totowa, Vol. 1124, 405-412. https://doi.org/10.1007/978-1-62703-845-4_23
|
[4]
|
Pandey, R., Singh, M., Singhal, U., Gupta, K.B. and Aggarwal, S.K. (2013) Oxidative/Nitrosative Stress and the Pathobiology of Chronic Obstructive Pulmonary Disease. Journal of Clinical and Diagnostic Research, 7, 580-588.
https://doi.org/10.7860/JCDR/2013/4360.2832
|
[5]
|
Singh, S., Verma, S.K., Kumar, S., Ahmad, M.K., Nischal, A., Singh, S.K., et al. (2017) Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease. Scandinavian Journal of Immunology, 85, 130-137.
https://doi.org/10.1111/sji.12498
|
[6]
|
Lakhdar, R., Denden, S., Kassab, A., Leban, N., Knani, J., Lefranc, G., et al. (2011) Update in Chronic Obstructive Pulmonary Disease: Role of Antioxidant and Metabolizing Gene Polymorphisms. Experimental Lung Research, 37, 364-375. https://doi.org/10.3109/01902148.2011.580416
|
[7]
|
Sarir, H., Mortaz, E., Janse, W.T., Givi, M.E., Nijkamp, F.P. and Folkerts, G. (2010) IL-8 Production by Macrophages Is Synergistically Enhanced When Cigarette Smoke Is Combined with TNF-Alpha. Biochemical Pharmacology, 79, 698-705. https://doi.org/10.1016/j.bcp.2009.10.001
|
[8]
|
Manevich, Y. and Fisher, A.B. (2005) Peroxiredoxin 6, a 1-Cys Peroxiredoxin, Functions in Antioxidant Defense and Lung Phospholipid Metabolism. Free Radical Biology and Medicine, 38, 1422-1432.
https://doi.org/10.1016/j.freeradbiomed.2005.02.011
|
[9]
|
Chowdhury, I., Mo, Y., Gao, L., Kazi, A., Fisher, A.B. and Feinstein, S.I. (2009) Oxidant Stress Stimulates Expression of the Human Peroxiredoxin 6 Gene by a Transcriptional Mechanism Involving an Antioxidant Response Element. Free Radical Biology and Medicine, 46, 146-153. https://doi.org/10.1016/j.freeradbiomed.2008.09.027
|
[10]
|
Fischer, B.M., Voynow, J.A. and Ghio, A.J. (2015) COPD: Balancing Oxidants and Antioxidants. International Journal of Chronic Obstructive Pulmonary Disease, 10, 261-276. https://doi.org/10.2147/COPD.S42414
|
[11]
|
Zinellu, E., Zinellu, A., Fois, A.G., Fois, S.S., Piras, B., Carru, C., et al. (2020) Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 4982324. https://doi.org/10.1155/2020/4982324
|
[12]
|
McGuinness, A.J. and Sapey, E. (2017) Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms. Journal of Clinical Medicine, 6, Article No. 21. https://doi.org/10.3390/jcm6020021
|
[13]
|
Ko, F.W., Lau, C.Y., Leung, T.F., Wong, G.W.K., Lam, C.W.K. and Hui, D.S.C. (2006) Exhaled Breath Condensate Levels of 8-Isoprostane, Growth Related Oncogene Alpha and Monocyte Chemoattractant Protein-1 in Patients with Chronic Obstructive Pulmonary Disease. Respiratory Medicine, 100, 630-638.
https://doi.org/10.1016/j.rmed.2005.08.009
|
[14]
|
Tamarit, J., de Hoogh, A., Obis, E., Alsina, D., Cabiscol, E. and Ros, J. (2012) Analysis of Oxidative Stress-Induced Protein Carbonylation Using Fluorescent Hydrazides. Journal of Proteomics, 75, 3778-3788.
https://doi.org/10.1016/j.jprot.2012.04.046
|
[15]
|
Bhalla, D.K. (1999) Ozone-Induced Lung Inflammation and Mucosal Barrier Disruption: Toxicology, Mechanisms, and Implications. Journal of Toxicology and Environmental Health, Part B, 2, 31-86.
https://doi.org/10.1080/109374099281232
|
[16]
|
Zhang, W.Z., Oromendia, C., Kikkers, S.A., Butler, J.J., O’Beirne, S., Kim, K., et al. (2020) Increased Airway Iron Parameters and Risk for Exacerbation in COPD: An Analysis from SPIROMICS. Scientific Reports, 10, Article No. 10562. https://doi.org/10.1038/s41598-020-67047-w
|
[17]
|
Khosravi, M., Poursaleh, A., Ghasempour, G., Farhad, S. and Najafi, M. (2019) The Effects of Oxidative Stress on the Development of Atherosclerosis. Biological Chemistry, 400, 711-732. https://doi.org/10.1515/hsz-2018-0397
|
[18]
|
Pignatelli, P., Menichelli, D., Pastori, D. and Violi, F. (2018) Oxidative Stress and Cardiovascular Disease: New Insights. Kardiologia Polska, 76, 713-722. https://doi.org/10.5603/KP.a2018.0071
|
[19]
|
Förstermann, U., Xia, N. and Li, H. (2017) Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circulation Research, 120, 713-735. https://doi.org/10.1161/CIRCRESAHA.116.309326
|
[20]
|
Virdis, A., Duranti, E. and Taddei, S. (2011) Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. International Journal of Hypertension, 2011, Article ID: 916310. https://doi.org/10.4061/2011/916310
|
[21]
|
Li, H., Horke, S. and Förstermann, U. (2014) Vascular Oxidative Stress, Nitric Oxide and Atherosclerosis. Atherosclerosis, 237, 208-219. https://doi.org/10.1016/j.atherosclerosis.2014.09.001
|
[22]
|
Meza, C.A., La Favor, J.D., Kim, D.H. and Hickner, R.C. (2019) Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? International Journal of Molecular Sciences, 20, Article No. 3775.
https://doi.org/10.3390/ijms20153775
|
[23]
|
Senoner, T. and Dichtl, W. (2019) Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? Nutrients, 11, Article No. 2090. https://doi.org/10.3390/nu11092090
|
[24]
|
Quesada, I.M., Lucero, A., Amaya, C., Meijles, D.N., Cifuentes, M.E., Pagano, P.J., et al. (2015) Selective Inactivation of NADPH Oxidase 2 Causes Regression of Vascularization and the Size and Stability of Atherosclerotic Plaques. Atherosclerosis, 242, 469-475. https://doi.org/10.1016/j.atherosclerosis.2015.08.011
|
[25]
|
Yu, M., Jiang, M., Chen, Y., Zhang, S., Zhang, W., Yang, X., et al. (2016) Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A Peroxisome Proliferator-Activated Receptor (Ppar)γ-Dependent Mechanism. Journal of Biological Chemistry, 291, 16977-16989.
https://doi.org/10.1074/jbc.M116.740092
|
[26]
|
Dyrøy, E., Røst, T.H., Pettersen, R.J., Halvorsen, B., Gudbrandsen, O.A., Ueland, T., et al. (2007) Tetradecylselenoacetic Acid, a PPAR Ligand with Antioxidant, Antiinflammatory, and Hypolipidemic Properties. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 628-634. https://doi.org/10.1161/01.ATV.0000255950.70774.d5
|
[27]
|
Shen, Y., Yang, T., Guo, S., Li, X., Chen, L., Wang, T., et al. (2013) Increased Serum ox-LDL Levels Correlated with Lung Function, Inflammation, and Oxidative Stress in COPD. Mediators of Inflammation, 2013, Article ID: 972347.
https://doi.org/10.1155/2013/972347
|
[28]
|
Ambrosino, P., Lupoli, R., Iervolino, S., De Felice, A., Pappone, N., Storino, A., et al. (2017) Clinical Assessment of Endothelial Function in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review with Meta-Analysis. Internal and Emergency Medicine, 12, 877-885. https://doi.org/10.1007/s11739-017-1690-0
|